Alternative methods in toxicology and ecotoxicology: the use of transcriptomics to define chemical profile
|
|
- Angel Shaw
- 8 years ago
- Views:
Transcription
1 Alternative methods in toxicology and ecotoxicology: the use of transcriptomics to define chemical profile Annamaria Colacci Environmental Protection and Health Prevention Agency
2 Environmental Carcinogenesis and Risk Assessment Center Experimental Toxicology Area Alternative methods to animal testing to screen carcinogens as single molecules or complex mixtures In vitro cell transformation (CE Reg 440/2008) Toxicogenomics Area Microarray technology (transcriptomics) CGH Risk assessment
3 BALB/c 3T3 Transformation Test International experience good degree of concordance with the in vivo rodent carcinogenesis tests (IARC/NCI/EPA Working Group 1989, 1993, OECD Working Group 2006) proposed use as a screening test for the carcinogenic potential of compounds that have no evidence of genotoxicity the experimental protocol is currently undergoing a prevalidation study which is coordinated by ECVAM Our experience (since 1988) 32 Single compounds Solvents Pesticides Pharmcological molecules Algal biotoxins 11 Complex mixtures Extracts from environmental media (soil, water, air) Complex mixtures to be introduced into the environment (fuels) Ionizing radiation Asbestos replacement fibers
4 Transformation test: BALB/c 3T3 model Cytotoxicity test - 48hr 0 48 hr 96 hr days carcinogen END POINT Cell seeding (250 cells) treatment 48 hours Medium change Fix and stain CLONAL EFFICIENCY Transformation test - 48hr 0 48 hr 96 hr days carcinogen Cell seeding (3 x 10 4 cells) Treatment 48 hours Medium change (twice a week) Fix and stain END POINT TRANSFORMATION FREQUENCY
5 Toxicological profiling Cytotoxicity toxic activity of the assayed compound/mixture (acute effects) Dose-response effects in order to choose the working doses for further experiments Transformation test potential carcinogenicity of the tested chemical to be compared with a positive control Dose response relationships Estimating a dose-response curve Data extrapolation for a quantitative assessment of the risk and/or identification of a threshold dose
6 Toxicological profile of the polycrystalline oxide fibers (PCF) in comparison with refractory ceramic fibers (RCF) and crocidolite Cells were exposed to RFC and PCF ( µg/cm 2 ) for 48 hrs to assess the effects on cloning efficiency % growth * * Cytotoxicity RCF PCF fiber concentration (µg/cm 2 ) Cells were exposed to RFC and PCF ( µg/cm 2 ) to estimate the occurrence of transformed foci TF (x 10-4 ) RCF PCF Cell transformation * µg/cm 2
7 % growth Toxicological profile of the polycrystalline oxide fibers (PCF) in comparison with refractory ceramic fibers (RCF) and crocidolite * Cytotoxicity * * fibers/cm 2 (x 10 3 ) RCF PCF CROCIDOLITE Evaluation of the dose-response relationship Identification of the critical parameters for the adverse effects of fibers Dose (Number of fibers) Dimensions Physical-chemical composition Reactivity of the surface Evaluation of the molecular mechanisms related to the biological effects of the fibers Screening of the effects of new man-made fibers Opportunity of comparative studies with natural fibers TF (x 10-4 ) Cell transformation * 0 RCF PCF CROCIDOLITE * * fibers/cm 2 (x 10 3 ) Some parameters, such as durability and biopersistence, which are essential for the pathogenesis of fibers, are strictly dependent on the microenvironment of the lung
8 Ionizing radiation exposure in BALB/c 3T3 cells Exponentially growing BALB/c 3T3 cells were γ-irradiated ( Gy) by exposure to 137 Cs radiation source Mean of colonies ± E.S. 0 (IBL 437C; 0.66 MeV; Gy Dose-rate 221 cgy/min) Cell transformation * Cytotoxicity * T.F. x Gy
9 From biological endpoints to genomic endpoints: the use of toxicogenomics approach 0.25, 0.75 and 3 Gy doses were selected because of their biological different behaviour: 0.25 Gy irradiation produced an increase in cellular proliferation without inducing foci formation 0.75 Gy irradiation was able to produce an increment of cellular growth rate and of foci occurrence, but not in a statistically significant way 3 Gy irradiation had an extremely toxic effect on clonal efficiency and a strong transforming activity
10 TOXICOGENOMICS In recent years, completion of the sequencing of the human genome as well as the genomes of dozens of other organisms and subsequent development of tools for comprehensive gene analysis have revolutionized biology. These new technologies, referred as genomics, have integrated biologic sciences with information sciences and engineering.
11 Toxicogenomics: an approach to investigate the gene-environment interaction Toxicogenomics is defined as the application of genomic technologies to toxicology, to study the adverse effects of environmental and pharmaceutical chemicals to define the toxicological profile of chemicals Fingerprints to evaluate the risk from exposure to understand the mechanism of action of chemicals to highlight individual susceptibilities to identify biomarkes of exposure and risk
12 Overview of the Toxicogenomic Technologies Toxicogenomic technologies comprise several different technology platforms for analysis of genomes, transcripts, proteins, and metabolites. Produce a large quantity of information and the comprehensive nature of this information, is much greater than what traditional experiments generate. The advancement of computing power and techniques enable these large amounts of information to be synthesized from different sources and experiments and to be analyzed in novel ways.
13 Use of transcriptomics The utility of transcriptional profiling as a sensitive method to classify cells, identify the response to pharmacological treatment and determine good or poor prognosis has been demonstrated 60 cell lines from diverse tumor tissues were classified based solely on the observed patterns of gene expression which corresponded to the tissue of origin from which the cell lines originated. (Ross et al. 2000). 70,000 antitumor drugs were then tested against the 60 cell lines for mrna expression profile to derive sensitivity to therapy, on the basis of molecular characteristics of a patient tumour. (Scherf et al. 2000) A 70-gene prognosis profile was established using microarray analysis to evaluate patient s prognosis for breast cancer (van de Vijver, 2002).
14 Transcriptomics and biomarkers of effect Transcriptomics begins to be applied to the screening of chemical compounds for identifying the chemical hazard or the mechanisms of action. It involves: measuring gene changes in response to specific doses of an administered test compound at specific time points evaluating molecular mechanisms of toxic action by sorting transcripts changes into groups of selected biological processes studying the degree of conservation of biologic response pathways across species that are responsible for toxicity
15 Transcriptomics at our lab Since 2001 Morandi et al. (2006) A cdna-microarray analysis of camptothecin resistance in glioblastoma cell lines. Cancer Lett., 231, Maffei et al. (2007) Angiopoietin-2 expression in B-cell chronic lymphocytic leukemia: association with clinical outcome and immunoglobulin heavy-chain mutational status. Leukemia, 21: Morandi et al.(2008) Gene expression time-series analysis of camptothecin effects in U87-MG and DBTRG-05 glioblastoma cell lines Mol Cancer. 7: 66 Morandi et al (2009) Gene expression changes in medical workers exposed to radiation Radiat Res. 72(4): Perdichizzi et al (2010) Biomarkers identification of ionizing radiation exposure in BALB/c 3T3 model (in preparation)
16 Lab ER-EPA O 3 : 5µg/m 3
17 Dual-colour gene expression analysis Not exposed cells (control) Exposed cells RNA RNA RNA purification and quality control (Agilent Bioanalyser 2100) ibridation RNA labeling (direct labeling linear amplification Hybridyzation of cy3- and cy5-labeled samples to 60-mer oligo microarray Washing Centro Tematico Regionale Cancerogenesi scanner Ambientale e Valutazione del Rischio Scan (Agilent scanner) Drying under nitrogen
18
19 Microarray analysis of irradiated BALB/c 3T3 cells Two different analysis were performed: in order to highlight the gene expression profile specific for cells exposed to 0.25 Gy (NT vs 0.25 Gy) in order to achieve information about differences among the three doses (0.25 vs 0.75 vs 3 Gy)
20 histones higher levels after 0.25 Gy irradiation indicate an active S-phase compared to 0.75 and 3 Gy irradiation Gy 0.75 Gy 3 Gy MeanLog 2 Ratio H3f3a H3f3b Hist1h1d Hist1h2ac Hist1h2bc Hist1h4i Hist2h4
21 Identification of possible endocrine disruptors by toxicogenomics approach Which genes are transcriptionally modulated by the fungicide penconazol in T47D cells? We tested four concentrations based on the sensitivity of the cellular model to penconazol A reference design, including two technical replicates for each point, was used ppm 0.05µM ppm 0.5µM ( LMR) 1.4 ppm 5µM 4.26 ppm 15µM ( GI50) NT
22 Penconazol data-set analysis Gene Spring GX Base-line to median of all samples Dose interpretation 1 way Anova, p<0.05; Benjamini-Hochberg correction 1874 modulated gene (preliminary results)
23 OECD SERIES ON TESTING AND ASSESSMENT, 29-Apr Number 50, REPORT OF THE OECD/IPCS WORKSHOP ON TOXICOGENOMICS, Kyoto, October 2004 The term ecotoxicogenomics describes the integration of genomics into ecotoxicology. The Population and Molecular Stress Responses of Daphnia magna Slide for studying the gene profile (3000 genes) Response to cadmium Environ Sci Technol Mar, Linking molecular and population stress responses in Daphnia magna exposed to cadmium.
24 From ecotoxicology to ecotoxicogenomics Microtox toxicity test system is a standardised toxicity test system which is rapid, sensitive, reproducible, ecologically relevant and cost effective. It accurately measure toxicity from water and other environmental samples, but it is also used to test the toxicity of single compounds It is based upon a bioluminescent marine bacterium (Vibrio fischeri) as the test organism. The bacteria are exposed to a range of concentrations of the material being tested. The change in light output and concentration of the toxicant produce a dose / response relationship. The results are normalised and the EC50 (concentration producing a 50% reduction in light) is calculated Excellent correlation with the toxicity values for fish, crustaceans and algae for a wide range of organic and inorganic chemicals
25 The design of a Vibrio fischeri slide By using the sequences from V. fischeri strain ES114, from the squid Euprymna scolopes, we were able to design a microarray slide with V. fischeri genome 8 x 15K slide 3 replicates of the entire genome mer-probes 371 probes from V. cholerae (specificity control)
26 The use of a Vibrio fischeri slide to discriminate toxicological profiles 11.2 mg/l FB1+5.6 FB2 (3:1) 16 mg/l, FB1 in triplicates 16 mg/l, FB2 FB1+FB2 Gene Spring GX: 1-way ANOVA FDR p<0.05 PCA FB1 FB2 DMSO
27 Annamaria Colacci Monica Vaccari Paola Silingardi Maria Grazia Mascolo Francesca Rotondo Elena Morandi Stefania Perdichizzi
28 VISIT THANK YOU
PRACTICAL APPROACH TO ECOTOXICOGENOMICS
ANNOUNCEMENT PRACTICAL APPROACH TO ECOTOXICOGENOMICS Advanced Workshop Studies in Biology and Applied Biosciences Department of Biology University of Aveiro, 30 April- 4 May 2007 This one-week post-graduate
More informationR. Julian Preston NHEERL U.S. Environmental Protection Agency Research Triangle Park North Carolina. Ninth Beebe Symposium December 1, 2010
Low Dose Risk Estimation: The Changing Face of Radiation Risk Assessment? R. Julian Preston NHEERL U.S. Environmental Protection Agency Research Triangle Park North Carolina Ninth Beebe Symposium December
More informationBiological importance of metabolites. Safety and efficacy aspects
Biological importance of metabolites Safety and efficacy aspects Bernard Walther Technologie Servier Biological importance of metabolites Safety testing of drug metabolites Bioanalytical strategy Structural
More informationGUIDELINES FOR THE REGISTRATION OF BIOLOGICAL PEST CONTROL AGENTS FOOD AND AGRICULTURE ORGANIZATION OF THE UNITED NATIONS
GUIDELINES FOR THE REGISTRATION OF BIOLOGICAL PEST CONTROL AGENTS FOOD AND AGRICULTURE ORGANIZATION OF THE UNITED NATIONS -ii- GUIDELINES ON THE REGISTRATION OF BIOLOGICAL PEST CONTROL AGENTS FOOD AND
More informationChemical safety and big data: the industry s demands
Chemical safety and big data: the industry s demands Richard CURRIE Senior Technical Expert; Group Leader & Global Predictive and Computational Toxicology Lead Valid results Useful results Credit Money/Grants
More informationBasic Overview of Preclinical Toxicology Animal Models
Basic Overview of Preclinical Toxicology Animal Models Charles D. Hebert, Ph.D., D.A.B.T. December 5, 2013 Outline Background In Vitro Toxicology In Vivo Toxicology Animal Models What is Toxicology? Background
More informationAnalysis of gene expression data. Ulf Leser and Philippe Thomas
Analysis of gene expression data Ulf Leser and Philippe Thomas This Lecture Protein synthesis Microarray Idea Technologies Applications Problems Quality control Normalization Analysis next week! Ulf Leser:
More informationINTERNATIONAL CONFERENCE ON HARMONISATION OF TECHNICAL REQUIREMENTS FOR REGISTRATION OF PHARMACEUTICALS FOR HUMAN USE S1A. Current Step 4 version
INTERNATIONAL CONFERENCE ON HARMONISATION OF TECHNICAL REQUIREMENTS FOR REGISTRATION OF PHARMACEUTICALS FOR HUMAN USE ICH HARMONISED TRIPARTITE GUIDELINE GUIDELINE ON THE NEED FOR CARCINOGENICITY STUDIES
More informationGuidance for Industry
Guidance for Industry S9 Nonclinical Evaluation for Anticancer Pharmaceuticals U.S. Department of Health and Human Services Food and Drug Administration Center for Drug Evaluation and Research (CDER) Center
More informationNONCLINICAL EVALUATION FOR ANTICANCER PHARMACEUTICALS
INTERNATIONAL CONFERENCE ON HARMONISATION OF TECHNICAL REQUIREMENTS FOR REGISTRATION OF PHARMACEUTICALS FOR HUMAN USE ICH HARMONISED TRIPARTITE GUIDELINE NONCLINICAL EVALUATION FOR ANTICANCER PHARMACEUTICALS
More informationAsbestos & Cancer: An Update. Suresh H. Moolgavkar, M.D., Ph.D.
Asbestos & Cancer: An Update Suresh H. Moolgavkar, M.D., Ph.D. Fiber Type and Cancer Epidemiological data clearly indicate that not all fiber types have the same potency as carcinogens. With respect to
More informationWHAT S NEW IN ALTERNATIVES?
WHAT S NEW IN ALTERNATIVES? Joanne Zurlo, PhD Center for Alternatives to Animal Testing (CAAT) Johns Hopkins Bloomberg School of Public Health Baltimore, MD What are alternatives? Alternative are sometimes
More informationMicroarray Technology
Microarrays And Functional Genomics CPSC265 Matt Hudson Microarray Technology Relatively young technology Usually used like a Northern blot can determine the amount of mrna for a particular gene Except
More informationIntroduction. MassDEP, Office of Research and Standards 1 Tetrachloroethylene
Summary of the Basis of Cancer Risk Values for Massachusetts Department of Environmental Protection (MassDEP) Office of Research and Standards January 22, 2014 Introduction In February 2012 the United
More informationFighting the Battles: Conducting a Clinical Assay
Fighting the Battles: Conducting a Clinical Assay 6 Vocabulary: In Vitro: studies in biology that are conducted using components of an organism that have been isolated from their usual biological surroundings
More informationOECD FELLOWSHIP SUMMARY REPORT
OECD FELLOWSHIP SUMMARY REPORT Name: Rolf Altenburger Subject: Status and research need in toxicogenomic mixture toxicity analysis Host Institution: University of Queensland, Brisbane, QLD Host Supervisor:
More informationOutline. Predictive Assays in Radiation Therapy Immunotherapy in Cancer Treatment. Introduction. Current clinical practice
Predictive Assays in Radiation Therapy Immunotherapy in Cancer Treatment Radiation Biology Outline Introduction: Predictive assays in radiation therapy Examples for specific tumors Immunotherapy Summary
More informationICH Topic S 1 A The Need for Carcinogenicity Studies of Pharmaceuticals. Step 5
European Medicines Agency July 1996 CPMP/ICH/140/95 ICH Topic S 1 A The Need for Carcinogenicity Studies of Pharmaceuticals Step 5 NOTE FOR GUIDANCE ON THE NEED FOR CARCINOGENICITY STUDIES OF PHARMACEUTICALS
More information2.1.2 Characterization of antiviral effect of cytokine expression on HBV replication in transduced mouse hepatocytes line
i 1 INTRODUCTION 1.1 Human Hepatitis B virus (HBV) 1 1.1.1 Pathogenesis of Hepatitis B 1 1.1.2 Genome organization of HBV 3 1.1.3 Structure of HBV virion 5 1.1.4 HBV life cycle 5 1.1.5 Experimental models
More informationGuidance for Industry Safety Testing of Drug Metabolites
Guidance for Industry Safety Testing of Drug Metabolites U.S. Department of Health and Human Services Food and Drug Administration Center for Drug Evaluation and Research (CDER) February 2008 Pharmacology
More informationRecombinant DNA and Biotechnology
Recombinant DNA and Biotechnology Chapter 18 Lecture Objectives What Is Recombinant DNA? How Are New Genes Inserted into Cells? What Sources of DNA Are Used in Cloning? What Other Tools Are Used to Study
More informationCOMMITTEE FOR PROPRIETARY MEDICINAL PRODUCTS (CPMP) NOTE FOR GUIDANCE ON THE PRE-CLINICAL EVALUATION OF ANTICANCER MEDICINAL PRODUCTS
The European Agency for the Evaluation of Medicinal Products Human Medicines Evaluation Unit London, 23 July 1998 COMMITTEE FOR PROPRIETARY MEDICINAL PRODUCTS (CPMP) NOTE FOR GUIDANCE ON THE PRE-CLINICAL
More informationCD22 Antigen Is Broadly Expressed on Lung Cancer Cells and Is a Target for Antibody-Based Therapy
CD22 Antigen Is Broadly Expressed on Lung Cancer Cells and Is a Target for Antibody-Based Therapy Joseph M. Tuscano, Jason Kato, David Pearson, Chengyi Xiong, Laura Newell, Yunpeng Ma, David R. Gandara,
More informationThe Science of Chemical Safety Essential Toxicology - 4. Hazard and Risk. John Duffus & Howard Worth. IUPAC Educators Resource Material IUPAC
The Science of Chemical Safety Essential Toxicology - 4 Hazard and Risk John Duffus & Howard Worth IUPAC Educators Resource Material IUPAC Hazard and Risk - 1 Hazard is the potential of a substance to
More informationH. Richard Alexander, Jr., M.D. Department of Surgery and The Greenebaum Cancer Center University of Maryland School of Medicine Baltimore, Md
Major Advances in Cancer Prevention, Diagnosis and Treatment~ Why Mesothelioma Leads the Way H. Richard Alexander, Jr., M.D. Department of Surgery and The Greenebaum Cancer Center University of Maryland
More information1) Aug 2005 In Vitro Chromosomal Aberration Study Cytotoxicity (File: TS39) Conclusion No cytotoxicity can be detected at concentrations up to 100%.
Endotoxicity and Cytotoxicity Studies 1) Aug 2005 In Vitro Chromosomal Aberration Study Cytotoxicity (File: TS39) Chinese Hamster Ovary (CHO) cells were grown in monolayer with and without metabolic activation.
More informationNATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES Division of Extramural Research and Training
NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES Division of Extramural Research and Training NATIONAL ADVISORY ENVIRONMENTAL HEALTH SCIENCES COUNCIL May 12-13, 2010 Concept Clearance Small Business
More informationOverview of Phase 1 Oncology Trials of Biologic Therapeutics
Overview of Phase 1 Oncology Trials of Biologic Therapeutics Susan Jerian, MD ONCORD, Inc. February 28, 2008 February 28, 2008 Phase 1 1 Assumptions and Ground Rules The goal is regulatory approval of
More informationCorrelation of microarray and quantitative real-time PCR results. Elisa Wurmbach Mount Sinai School of Medicine New York
Correlation of microarray and quantitative real-time PCR results Elisa Wurmbach Mount Sinai School of Medicine New York Microarray techniques Oligo-array: Affymetrix, Codelink, spotted oligo-arrays (60-70mers)
More informationModule Three. Risk Assessment
Module Three Risk Assessment 136 Module Three Introduction to Risk Assessment Time Allotted: 90 Minutes Objectives: Upon completion of this module, the learner will be able to # Define and understand the
More informationMolecular Genetics: Challenges for Statistical Practice. J.K. Lindsey
Molecular Genetics: Challenges for Statistical Practice J.K. Lindsey 1. What is a Microarray? 2. Design Questions 3. Modelling Questions 4. Longitudinal Data 5. Conclusions 1. What is a microarray? A microarray
More informationStrategies in data integration to predict fish susceptibility to toxicants
Strategies in data integration to predict fish susceptibility to toxicants Fernando Ortega and Francesco Falciani School of Biosciences The University of Birmingham NERC PGP Project Kevin Chipman Mark
More informationM110.726 The Nucleus M110.727 The Cytoskeleton M340.703 Cell Structure and Dynamics
of Biochemistry and Molecular Biology 1. Master the knowledge base of current biochemistry, molecular biology, and cellular physiology Describe current knowledge in metabolic transformations conducted
More informationGPS Safety Summary. Cyclododeca-1,5,9-triene. Technical information. Substance name. Cyclododeca-1,5,9-triene CAS No. 4904-61-4.
Technical information GPS Safety Summary Substance name CAS No. 4904-61-4 General Statement This Product Safety Summary is intended to provide a general overview of the chemical substance. The information
More informationSession 6 Clinical Trial Assessment Phase I Clinical Trial
L1 Session 6 Clinical Trial Assessment Phase I Clinical Trial Presentation to APEC Preliminary Workshop on Review of Drug Development in Clinical Trials Celia Lourenco, PhD, Manager, Clinical Group I Office
More informationAppendix 2 Molecular Biology Core Curriculum. Websites and Other Resources
Appendix 2 Molecular Biology Core Curriculum Websites and Other Resources Chapter 1 - The Molecular Basis of Cancer 1. Inside Cancer http://www.insidecancer.org/ From the Dolan DNA Learning Center Cold
More informationRADIOPHARMACEUTICALS BASED ON MONOCLONAL ANTIBODIES
RADIOPHARMACEUTICALS BASED ON MONOCLONAL ANTIBODIES Guideline Title Radiopharmaceuticals based on Monoclonal Antibodies Legislative basis Directives 65/65/EEC, 75/318/EEC as amended, Directive 89/343/EEC
More informationEdward Odenkirchen, Ph.D. Office of Pesticide Programs US Environmental Protection Agency
Edward Odenkirchen, Ph.D. Office of Pesticide Programs US Environmental Protection Agency 1 Mission Statement Best possible regulatory decisions to protect public health and environment. Rely on all best
More informationBiophysical and biochemical mechanisms of the biological effects of mobile phone radiation
Biophysical and biochemical mechanisms of the biological effects of mobile phone radiation Dariusz Leszczynski Research Professor; STUK - Radiation and Nuclear Safety Authority Helsinki, Finland & Guangbiao
More information- A9/1 - Format for the listing of end points to be included in the Tier III overall summary and assessments
- A9/1 - - A9/1 - APPENDIX 9 FORMAT FOR THE LISTING OF END POINTS TO BE INCLUDED IN THE REASONED STATEMENT OF THE OVERALL CONCLUSIONS DRAWN BY THE REGULATORY AUTHORITY (LEVEL 2)8 General remark: Testing
More informationdixa a data infrastructure for chemical safety Jos Kleinjans Dept of Toxicogenomics Maastricht University
dixa a data infrastructure for chemical safety Jos Kleinjans Dept of Toxicogenomics Maastricht University Current protocol for chemical safety testing Short Term Tests for Genetic Toxicity Bacterial Reverse
More informationPERFORMANCE STANDARDS. For assessment of proposed similar or modified in vitro skin sensitisation ARE-Nrf2 luciferase test methods
PERFORMANCE STANDARDS For assessment of proposed similar or modified in vitro skin sensitisation ARE-Nrf2 luciferase test methods (Intended for the developers of new or modified similar test methods) INTRODUCTION
More informationOverview on EFSA data requirements for the safety evaluation of food enzymes applications
Overview on EFSA data requirements for the safety evaluation of food enzymes applications Fidel Toldrá and Klaus-Dieter Jany EFSA CEF Panel Info session on Food Enzymes applications Parma, 27 May 2014
More informationTECHNICAL INSIGHTS TECHNOLOGY ALERT
TECHNICAL INSIGHTS TECHNOLOGY ALERT UNLOCKING BREAST CANCER TUMORS' DRUG RESISTANCE A troubling phenomenon in breast cancer treatment is that some patients tumors become resistant to treatments over time.
More informationBiochemistry. Entrance Requirements. Requirements for Honours Programs. 148 Bishop s University 2015/2016
148 Bishop s University 2015/2016 Biochemistry The Biochemistry program at Bishop s is coordinated through an interdisciplinary committee of chemists, biochemists and biologists, providing students with
More informationEnzyme Response Profiling: Integrating proteomics and genomics with xenobiotic metabolism and cytotoxicity
Enzyme Response Profiling: Integrating proteomics and genomics with xenobiotic metabolism and cytotoxicity Proteomics high throughput separation and characterization of expressed proteins in tissue and
More informationPharmacology skills for drug discovery. Why is pharmacology important?
skills for drug discovery Why is pharmacology important?, the science underlying the interaction between chemicals and living systems, emerged as a distinct discipline allied to medicine in the mid-19th
More informationGuidance for Industry
Guidance for Industry Codevelopment of Two or More New Investigational Drugs for Use in Combination U.S. Department of Health and Human Services Food and Drug Administration Center for Drug Evaluation
More informationNATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCEINCES Division of Extramural Research and Training
NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCEINCES Division of Extramural Research and Training NATIONAL ADVISORY ENVIRONMENTAL HEALTH SCIENCES COUNCIL May 20, 2009 Introduction Concept Clearance For
More informationIMPURITIES IN NEW DRUG PRODUCTS
INTERNATIONAL CONFERENCE ON HARMONISATION OF TECHNICAL REQUIREMENTS FOR REGISTRATION OF PHARMACEUTICALS FOR HUMAN USE ICH HARMONISED TRIPARTITE GUIDELINE IMPURITIES IN NEW DRUG PRODUCTS Q3B(R2) Current
More informationCell Phone Radiation and Genomic Damage: In Vitro Exposure and Assessment
Cell Phone Radiation and Genomic Damage: In Vitro Exposure and Assessment Chinar Shah 1, Anu Nair 1, Mehul Naik 2, Sonal Bakshi 3 Institute of Science, Nirma University, Ahmedabad, Gujarat, India 1 Electronics
More informationNew Advances in Cancer Treatments. March 2015
New Advances in Cancer Treatments March 2015 Safe Harbour Statement This presentation document contains certain forward-looking statements and information (collectively, forward-looking statements ) within
More informationMATHEMATICAL MODELS OF TUMOR GROWTH INHIBITION IN XENOGRAFT MICE AFTER ADMINISTRATION OF ANTICANCER AGENTS GIVEN IN COMBINATION
MATHEMATICAL MODELS OF TUMOR GROWTH INHIBITION IN XENOGRAFT MICE AFTER ADMINISTRATION OF ANTICANCER AGENTS GIVEN IN COMBINATION Nadia Terranova UNIVERSITÀ DI PAVIA New model development: course of action
More informationHow to create and interpret the predictive analysis of a compound
How to create and interpret the predictive analysis of a compound Platform with suite of tools Predict & understand biological effects of small molecules & compounds Predict targets and metabolites, potential
More informationIn Vivo and In Vitro Screening for Thyroid Hormone Disruptors
In Vivo and In Vitro Screening for Thyroid Hormone Disruptors Kevin M. Crofton National lhealth and Environmental Research Laboratory California Environmental Protection Agency Human Health Hazard Indicators
More informationEvaluation of focal adhesions as new therapeutic targets in acute myeloid leukemia
Evaluation of focal adhesions as new therapeutic targets in acute myeloid leukemia Dr Jordi Sierra Gil IRHSP Institut de Recerca Hospital de la Santa Creu i Sant Pau Dr. Miguel Ángel Sanz Alonso Fundación
More informationHow many of you have checked out the web site on protein-dna interactions?
How many of you have checked out the web site on protein-dna interactions? Example of an approximately 40,000 probe spotted oligo microarray with enlarged inset to show detail. Find and be ready to discuss
More informationThe Clinical Trials Process an educated patient s guide
The Clinical Trials Process an educated patient s guide Gwen L. Nichols, MD Site Head, Oncology Roche TCRC, Translational and Clinical Research Center New York DISCLAIMER I am an employee of Hoffmann-
More informationThe Need for a PARP in vivo Pharmacodynamic Assay
The Need for a PARP in vivo Pharmacodynamic Assay Jay George, Ph.D., Chief Scientific Officer, Trevigen, Inc., Gaithersburg, MD For further infomation, please contact: William Booth, Ph.D. Tel: +44 (0)1235
More informationM. Ugolini 1,2, G. Babini 1,2, G. Baiocco 1,2, D. Cappelletti 1,2, L. Mariotti 1,2, J. Morini 1,2,3 and A. Ottolenghi 1,2
M. Ugolini 1,2, G. Babini 1,2, G. Baiocco 1,2, D. Cappelletti 1,2, L. Mariotti 1,2, J. Morini 1,2,3 and A. Ottolenghi 1,2 1 Department of Physics, University of Pavia, Pavia, Italy 2 Istituto Nazionale
More informationPathway Analysis : An Introduction
Pathway Analysis : An Introduction Experiments Literature and other KB Data Knowledge Structure in Data through statistics Structure in Knowledge through GO and other Ontologies Gain insight into Data
More informationIn Silico Models: Risk Assessment With Non-Testing Methods in OSIRIS Opportunities and Limitations
In Silico Models: Risk Assessment With Non-Testing Methods in OSIRIS Opportunities and Limitations Mark Cronin, Mark Hewitt, Katarzyna Przybylak School of Pharmacy and Chemistry Liverpool John Moores University
More informationECOLOGICAL RISK ASSESSMENT (EcoRA)
ECOLOGICAL RISK ASSESSMENT (EcoRA) Methodology, role of ICTs and its consequence for data processing Dušek L., Holoubek I., Jarkovský J., Koptíková J., Kohout J., Šmíd R., Pavliš P., Mužík J., Hřebíček
More information岑 祥 股 份 有 限 公 司 技 術 專 員 費 軫 尹 20100803
技 術 專 員 費 軫 尹 20100803 Overview of presentation Basic Biology of RNA interference Application of sirna for gene function? How to study mirna? How to deliver sirna and mirna? New prospects on RNAi research
More informationQuantitative proteomics background
Proteomics data analysis seminar Quantitative proteomics and transcriptomics of anaerobic and aerobic yeast cultures reveals post transcriptional regulation of key cellular processes de Groot, M., Daran
More informationWhat is nanotoxicology?
What is nanotoxicology? How to estimate the potential hazard related to nanoparticles? Dissemination report October 2008 DR-225 200810-5 Project ID NMP2-CT-2005-515843 An European Integrated Project Supported
More informationMathematical Models of Supervised Learning and their Application to Medical Diagnosis
Genomic, Proteomic and Transcriptomic Lab High Performance Computing and Networking Institute National Research Council, Italy Mathematical Models of Supervised Learning and their Application to Medical
More informationMATERIAL SAFETY DATA SHEET
Page 1 of 5 1. IDENTIFICATION OF THE SUBSTANCE/PREPARATION AND THE COMPANY/UNDERTAKING Pfizer Inc Pfizer Pharmaceuticals Group 235 East 42nd Street New York, New York 10017 1-212-573-2222 Emergency telephone
More informationAre polyphenols the life extending structures in humic substances?
Are polyphenols the life extending structures in humic substances? From: J. Berger & R. Sommer, Max-Planck-Institut für Entwicklungsbiologie, Tübingen Nadine Saul 1, Kerstin Pietsch 1, Ralph Menzel 1,
More informationInhibition of MicroRNA Sensitizes 3D Breast Cancer Microtissues to Radiation Therapy
CASE STUDY High Content Image Analysis Inhibition of MicroRNA Sensitizes 3D Breast Cancer Microtissues to Radiation Therapy Dr. Nataša Anastasov leads the Personalized Radiation Therapy Group within the
More informationReal-time PCR: Understanding C t
APPLICATION NOTE Real-Time PCR Real-time PCR: Understanding C t Real-time PCR, also called quantitative PCR or qpcr, can provide a simple and elegant method for determining the amount of a target sequence
More informationUncertainty factors:
The Interdepartmental Group on Health Risks from Chemicals Uncertainty factors: Their use in human health risk assessment by UK Government cr9 The Interdepartmental Group on Health Risks from Chemicals
More information19/03/2012 Toxicologicalcharacterizationof PM10: case study Genk-Zuid. R. Van Den Heuvel
19/03/2012 Toxicologicalcharacterizationof PM10: case study Genk-Zuid. R. Van Den Heuvel Introduction» Assessment of potential risk to human health associated with environmental air» Fysico-chemical characterization»
More informationSupplementary Online Content
Supplementary Online Content Harshman, LC, Wang X, Nakabayashi M, et al. Statin use at the time of initiation of androgen deprivation therapy and time to progression in patients with hormone-sensitive
More informationAGILENT S BIOINFORMATICS ANALYSIS SOFTWARE
ACCELERATING PROGRESS IS IN OUR GENES AGILENT S BIOINFORMATICS ANALYSIS SOFTWARE GENESPRING GENE EXPRESSION (GX) MASS PROFILER PROFESSIONAL (MPP) PATHWAY ARCHITECT (PA) See Deeper. Reach Further. BIOINFORMATICS
More informationAlterações empresariais sustentadas pelo conceito de engenharia do Produto Patrício Soares da Silva, MD, PhD
Alterações empresariais sustentadas pelo conceito de engenharia do Produto Patrício Soares da Silva, MD, PhD 1 Summary Hypothesis Generation Candidate Development Commercialization Target Identification
More informationMolecular markers in radiation-induced thyroid cancer
MELODI 2012 workshop Helsinki 12 th - 14 th September, 2012 Molecular markers in radiation-induced thyroid cancer Horst Zitzelsberger Helmholtz Zentrum München Research Unit Radiation Cytogenetics Radiation
More information1 page Overview. CONCURRENT 1D, 1E, 1F Biology & Pathogenesis Multi-Modality Immunology 1
1 page Overview 21 Oct Tuesday 1500 on REGISTRATION 1800 Welcome Reception & Cocktails at the Cape Town International Conference Centre (CTICC) 22 Oct Wednesday 0730 REGISTRATION 0830 OPENING 0900 PLENARY
More informationComparison of Non-linear Dimensionality Reduction Techniques for Classification with Gene Expression Microarray Data
CMPE 59H Comparison of Non-linear Dimensionality Reduction Techniques for Classification with Gene Expression Microarray Data Term Project Report Fatma Güney, Kübra Kalkan 1/15/2013 Keywords: Non-linear
More informationChemical Risk Assessment in Absence of Adequate Toxicological Data
Chemical Risk Assessment in Absence of Adequate Toxicological Data Mark Cronin School of Pharmacy and Chemistry Liverpool John Moores University England m.t.cronin@ljmu.ac.uk The Problem Risk Analytical
More informationIntroduction To Real Time Quantitative PCR (qpcr)
Introduction To Real Time Quantitative PCR (qpcr) SABiosciences, A QIAGEN Company www.sabiosciences.com The Seminar Topics The advantages of qpcr versus conventional PCR Work flow & applications Factors
More informationEssentials of Real Time PCR. About Sequence Detection Chemistries
Essentials of Real Time PCR About Real-Time PCR Assays Real-time Polymerase Chain Reaction (PCR) is the ability to monitor the progress of the PCR as it occurs (i.e., in real time). Data is therefore collected
More informationspecific B cells Humoral immunity lymphocytes antibodies B cells bone marrow Cell-mediated immunity: T cells antibodies proteins
Adaptive Immunity Chapter 17: Adaptive (specific) Immunity Bio 139 Dr. Amy Rogers Host defenses that are specific to a particular infectious agent Can be innate or genetic for humans as a group: most microbes
More informationUpdate of the scientific evidence on asbestos and cancer. Kurt Straif, MD MPH PhD. The IARC Monographs
Update of the scientific evidence on asbestos and cancer Kurt Straif, MD MPH PhD International Agency for Research on Cancer Lyon, France World Health Organisation Asturias, 17 March 2011 The IARC Monographs
More informationESTABLISHMENT OF CELL LINES FOR MANUFACTURING RECOMBINANT ANTIBODIES. Dr Andrew Racher
ESTABLISHMENT OF CELL LINES FOR MANUFACTURING RECOMBINANT ANTIBODIES Dr Andrew Racher Lonza Biologics plc, 2004 Structure of talk Issues Selection of a high producing cell line Selection for process compatibility
More informationMATERIAL SAFETY DATA SHEET
MATERIAL SAFETY DATA SHEET 1. PRODUCT AND COMPANY IDENTIFICATION Name: XYLOCAINE SOLUTIONS WITH EPINEPHRINE Address/Phone No.: DENTSPLY Pharmaceutical 3427 Concord Road York, PA 17402 Phone: 717-757-0200
More informationPest Management Regulatory Agency
Pest Management Regulatory Agency Overview Document Introduction The Pest Management Regulatory Agency (PMRA) was established in April 1995 in response to the recommendations of the Pesticide Registration
More informationTargeting Specific Cell Signaling Pathways for the Treatment of Malignant Peritoneal Mesothelioma
The Use of Kinase Inhibitors: Translational Lab Results Targeting Specific Cell Signaling Pathways for the Treatment of Malignant Peritoneal Mesothelioma Sheelu Varghese, Ph.D. H. Richard Alexander, M.D.
More informationMeasuring gene expression (Microarrays) Ulf Leser
Measuring gene expression (Microarrays) Ulf Leser This Lecture Gene expression Microarrays Idea Technologies Problems Quality control Normalization Analysis next week! 2 http://learn.genetics.utah.edu/content/molecules/transcribe/
More informationAiping Lu. Key Laboratory of System Biology Chinese Academic Society APLV@sibs.ac.cn
Aiping Lu Key Laboratory of System Biology Chinese Academic Society APLV@sibs.ac.cn Proteome and Proteomics PROTEin complement expressed by genome Marc Wilkins Electrophoresis. 1995. 16(7):1090-4. proteomics
More informationWhat is Cancer? Cancer is a genetic disease: Cancer typically involves a change in gene expression/function:
Cancer is a genetic disease: Inherited cancer Sporadic cancer What is Cancer? Cancer typically involves a change in gene expression/function: Qualitative change Quantitative change Any cancer causing genetic
More informationMechanism of short-term ERK activation by electromagnetic fields at mobile phone frequencies. Biochemistry Journal. August 1, 2007 405, pp.
Mechanism of short-term ERK activation by electromagnetic fields at mobile phone frequencies 1 Biochemistry Journal August 1, 2007 405, pp. 559 568 Joseph Friedman, Sarah Kraus, Yirmi Hauptman, Yoni Schiff
More informationSABIDA - New biomarker identification tool
SABIDA - New biomarker identification tool Case study: Identification of safety biomarkers by integrating toxicogenomics datasets with biological networks (Merck Serono) Phil Hewith, PhD, Merck Serono
More informationApplication Note No. 2 / July 2012. Quantitative Assessment of Cell Quality, Viability and Proliferation. System
Application Note No. 2 / July 2012 Quantitative Assessment of Cell Quality, Viability and Proliferation System Quantitative Assessment of Cell Quality, Viability and Proliferation Introduction In vitro
More informationNon-clinical development of biologics
Aurigon Life Science GmbH Non-clinical development of biologics Requirements, challenges and case studies Committed to Life. Sigrid Messemer vet. med. M4 Seminar March 10 th 2014 Aurigon - your full service
More informationCancer - Dangers in the Process of High Butadiene and Network Marketing
Remarks on the cancer risk values of 1,3-butadiene (draft Dutch Health Council 2012) Author: Wil ten Berge Date: 19 January 2013 1 Introduction The Dutch Health Council (DHC) has issued a proposal for
More informationCytogenetic analysis of restoration workers for Fukushima Daiichi Nuclear Power Station accident
Cytogenetic analysis of restoration workers for Fukushima Daiichi Nuclear Power Station accident Yumiko Suto 1, Momoki Hirai 1, Miho Akiyama 1, Gen Kobashi 2, Masanari Itokawa 3, Nobuyuki Sugiura 1,4,
More informationROFERON-A PFS 3 M IU/0.5 ml
Safety Data Sheet ROFERON-A PFS 3 M IU/0.5 ml SECTION 1: Identification of the substance/mixture and of the company/undertaking 1.1. Product identifier Product name Product code ROFERON-A PFS 3 M IU/0.5
More informationBBSRC TECHNOLOGY STRATEGY: TECHNOLOGIES NEEDED BY RESEARCH KNOWLEDGE PROVIDERS
BBSRC TECHNOLOGY STRATEGY: TECHNOLOGIES NEEDED BY RESEARCH KNOWLEDGE PROVIDERS 1. The Technology Strategy sets out six areas where technological developments are required to push the frontiers of knowledge
More informationFuture Oncology: Technology, Products, Market and Service Opportunities
Brochure More information from http://www.researchandmarkets.com/reports/296370/ Future Oncology: Technology, Products, Market and Service Opportunities Description: Future Oncology is an analytical newsletter
More information